Christopher J Rust's Net Worth

$745 Million

Estimate Recalculated Feb 29, 2024 07:45PM EST

Who is Christopher J Rust?

Christopher J Rust has an estimated net worth of $745 Million. This is based on reported shares across multiple companies, which include IMPERVA INC, Guidewire Software, Inc., AtriCure, Inc., MAXLINEAR INC, OncoMed Pharmaceuticals Inc, LEADIS TECHNOLOGY INC, Altus Pharmaceuticals Inc., and INTERMOLECULAR INC.

SEC CIK

Christopher J Rust's CIK is 0001316575

Past Insider Trading and Trends

2011 was Christopher J Rust's most active year for acquiring shares with 19 total transactions. Christopher J Rust's most active month to acquire stocks was the month of October. 2012 was Christopher J Rust's most active year for disposing of shares, totalling 48 transactions. Christopher J Rust's most active month to dispose stocks was the month of October. 2011 saw Christopher J Rust paying a total of $2,752,542.00 for 8,628,401 shares, this is the most they've acquired in one year. In 2012 Christopher J Rust cashed out on 21,906,458 shares for a total of $98,431,979.17, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AtriCure, Inc. (ATRC) Snapshot price: $33.44

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-18.89%
-352.58K
1.51M
Jun 13
Form 4
-15.87%
-357.62K
$9.44
-$47,578.88
1.9M
Jun 6 - Jun 7
Form 4
+0.38%
8.47K
$5.62
$14,076.53
2.25M
Aug 10
Form 4
2.24M
$11.16
-$3,037,952.88
2.24M
Aug 10
Form 3
0
0
No matching records found

MAXLINEAR INC (MXL) Snapshot price: $17.41

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Aug 21
Form 4
-100.00%
-4.88K
$4.20
-$20,484.75
0
May 30
Form 4
4.88K
4.88K
May 15
Form 4
-100.00%
-6.96K
$8.95
-$62,339.74
0
May 27
Form 4
+5.50%
363
$8.93
-$40,279.08
6.96K
May 25 - May 26
Form 4
-36.82%
-3.85K
$11.54
-$44,399.37
6.6K
Feb 15
Form 4
10.45K
10.45K
Feb 7
Form 4
-100.00%
-4.42K
$10.54
-$46,520.86
0
Nov 29
Form 4/A
-33.10%
-1.45K
$10.52
-$15,281.20
2.94K
Nov 15
Form 4
-33.56%
-2.22K
$10.52
-$23,347.74
4.39K
Nov 15
Form 4
6.62K
6.62K
Nov 5
Form 4
-100.00%
-5.44M
$14.00
-$7,954,730.00
0
Mar 29
Form 4
5.44M
5.44M
Mar 29
No matching records found

Altus Pharmaceuticals Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-9.96%
-300.00K
$0.32
-$97,290.00
2.71M
Sep 14
Form 4
3.01M
3.01M
Jan 31
Form 3
0
0
No matching records found

INTERMOLECULAR INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.03%
-1.21K
$6.70
-$8,100.30
4.28M
Jun 14
Form 4
-4.86%
-218.63K
$6.76
-$1,478,268.28
4.28M
Jun 11 - Jun 13
Form 4
-7.00%
-338.50K
$6.55
-$2,217,344.25
4.5M
May 31
Form 4
-10.00%
-537.60K
4.84M
May 15
Form 4
5.38M
5.38M
Nov 23
No matching records found

LEADIS TECHNOLOGY INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-33.31%
-1.01M
2.02M
Jul 26
Form 3
0
0
Form 4
-24.99%
-1.01M
3.02M
May 25
Form 4
-19.99%
-1.00M
4M
Feb 1
No matching records found